ATE247660T1 - Furopyridinderivate und ihre therapeutische verwendung - Google Patents

Furopyridinderivate und ihre therapeutische verwendung

Info

Publication number: ATE247660T1
Authority: AT; Austria
Prior art keywords: therapeutic use; furopyridine derivatives; furopyridine; derivatives; andr2
Prior art date: 1998-06-08

Application number

AT99955472T

Other languages

English (en)

Inventor

Hazel Joan Dyke

Verity Margaret Sabin

Andrew Sharpe

Alan Findlay Haughan

Christopher Lowe

George Buckley

John Gary Montana

Original Assignee

Darwin Discovery Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-06-08

Filing date

1999-06-07

Publication date

2003-09-15

1998-06-08 Priority claimed from GBGB9812322.7A external-priority patent/GB9812322D0/en

1998-09-23 Priority claimed from GBGB9820768.1A external-priority patent/GB9820768D0/en

1999-06-07 Application filed by Darwin Discovery Ltd filed Critical Darwin Discovery Ltd

2003-09-15 Application granted granted Critical

2003-09-15 Publication of ATE247660T1 publication Critical patent/ATE247660T1/de

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Neurology (AREA)
Orthopedic Medicine & Surgery (AREA)
Pulmonology (AREA)
Neurosurgery (AREA)
Oncology (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Communicable Diseases (AREA)
Diabetes (AREA)
Tropical Medicine & Parasitology (AREA)
Virology (AREA)
Hematology (AREA)
Dermatology (AREA)
Psychiatry (AREA)
Heart & Thoracic Surgery (AREA)
Transplantation (AREA)
AIDS & HIV (AREA)
Ophthalmology & Optometry (AREA)
Hospice & Palliative Care (AREA)
Emergency Medicine (AREA)
Molecular Biology (AREA)
Otolaryngology (AREA)

AT99955472T 1998-06-08 1999-06-07 Furopyridinderivate und ihre therapeutische verwendung ATE247660T1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB9812322.7A GB9812322D0 (en)	1998-06-08	1998-06-08	Benzofurans and their therapeutic use
GBGB9820768.1A GB9820768D0 (en)	1998-09-23	1998-09-23	Heterocyclic compounds and their therapeutic use
PCT/GB1999/001791 WO1999064423A1 (en)	1998-06-08	1999-06-07	Furopyridine derivatives and their therapeutical use

Publications (1)

Publication Number	Publication Date
ATE247660T1 true ATE247660T1 (de)	2003-09-15

Family

ID=26313823

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT99955472T ATE247660T1 (de)	1998-06-08	1999-06-07	Furopyridinderivate und ihre therapeutische verwendung

Country Status (12)

Country	Link
US (1)	US6169090B1 (de)
EP (1)	EP1086106B1 (de)
JP (1)	JP2003526601A (de)
AT (1)	ATE247660T1 (de)
AU (1)	AU753897B2 (de)
CA (1)	CA2333629A1 (de)
CO (1)	CO5080802A1 (de)
DE (1)	DE69910568T2 (de)
ES (1)	ES2204171T3 (de)
PE (1)	PE20000734A1 (de)
TW (1)	TW555759B (de)
WO (1)	WO1999064423A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2381600A (en) *	1998-12-23	2000-07-31	Du Pont Pharmaceuticals Company	Thrombin or factor xa inhibitors
US7217722B2 (en)	2000-02-01	2007-05-15	Kirin Beer Kabushiki Kaisha	Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same
GB0003256D0 (en) *	2000-02-11	2000-04-05	Darwin Discovery Ltd	Heterocyclic compounds and their therapeutic use
WO2002012189A1 (fr) *	2000-08-09	2002-02-14	Mitsubishi Pharma Corporation	Composes amide bicycliques condenses et utilisations medicales associees
US6724220B1 (en)	2000-10-26	2004-04-20	Cyress Semiconductor Corporation	Programmable microcontroller architecture (mixed analog/digital)
US8176296B2 (en)	2000-10-26	2012-05-08	Cypress Semiconductor Corporation	Programmable microcontroller architecture
US6479493B1 (en)	2001-08-23	2002-11-12	Cell Pathways, Inc.	Methods for treatment of type I diabetes
KR20050108402A (ko) *	2003-03-17	2005-11-16	교와 핫꼬 고교 가부시끼가이샤	만성 피부 질환의 치료제 및/또는 예방제
DE10318610A1 (de) *	2003-04-24	2004-11-11	Elbion Ag	7-Azaindole und deren Verwendung als Therapeutika
US8069436B2 (en)	2004-08-13	2011-11-29	Cypress Semiconductor Corporation	Providing hardware independence to automate code generation of processing device firmware
JP5878327B2 (ja) *	2011-10-12	2016-03-08	花王株式会社	手洗い用食器洗浄剤組成物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4910193A (en)	1985-12-16	1990-03-20	Sandoz Ltd.	Treatment of gastrointestinal disorders
CA2144763A1 (en)	1992-10-14	1994-04-28	George D. Hartman	Fibrinogen receptor antagonists
WO1994012461A1 (en)	1992-12-02	1994-06-09	Pfizer Inc.	Catechol diethers as selective pdeiv inhibitors
DK0637586T3 (da)	1993-08-05	1999-12-06	Hoechst Marion Roussel Inc	2-(Piperidin-4-yl, pyridin-4-yl og tetrahydropyridin-4-yl)-benzofuran-7-carbamatderivater, deres fremstilling og anvendelse
JPH07267961A (ja) *	1994-03-30	1995-10-17	Taisho Pharmaceut Co Ltd	ベンゾフロ［３，２−ｄピリミジン−４−オン誘導体
WO1996036638A1 (en)	1995-05-19	1996-11-21	Chiroscience Limited	Xanthines and their therapeutic use
JPH09108832A (ja)	1995-10-19	1997-04-28	Mitsubishi Electric Corp	溶接構造体およびその溶接方法
EP0873331B1 (de) *	1995-12-05	2002-04-03	Darwin Discovery Limited	Benzofuran-carboxamide und -sulfonamide
SI0912568T1 (en) *	1996-05-15	2003-04-30	Altana Pharma Ag	Imidazopyridines
WO1997044337A1 (en) *	1996-05-20	1997-11-27	Darwin Discovery Limited	Benzofuran carboxamides and their therapeutic use
DE69717827T2 (de) *	1996-08-19	2003-09-04	Altana Pharma Ag	Benzofuran-4-carboxamide
JP4166296B2 (ja)	1997-04-25	2008-10-15	塩野義製薬株式会社	ドーパミン受容体拮抗作用を有する化合物

1999
- 1999-06-03 TW TW088109174A patent/TW555759B/zh active
- 1999-06-07 ES ES99955472T patent/ES2204171T3/es not_active Expired - Lifetime
- 1999-06-07 AT AT99955472T patent/ATE247660T1/de not_active IP Right Cessation
- 1999-06-07 WO PCT/GB1999/001791 patent/WO1999064423A1/en active IP Right Grant
- 1999-06-07 CA CA002333629A patent/CA2333629A1/en not_active Abandoned
- 1999-06-07 DE DE69910568T patent/DE69910568T2/de not_active Expired - Fee Related
- 1999-06-07 AU AU42776/99A patent/AU753897B2/en not_active Ceased
- 1999-06-07 JP JP2000553432A patent/JP2003526601A/ja active Pending
- 1999-06-07 EP EP99955472A patent/EP1086106B1/de not_active Expired - Lifetime
- 1999-06-08 US US09/328,182 patent/US6169090B1/en not_active Expired - Fee Related
- 1999-06-08 PE PE1999000510A patent/PE20000734A1/es not_active Application Discontinuation
- 1999-06-08 CO CO99035782A patent/CO5080802A1/es unknown

Also Published As

Publication number	Publication date
DE69910568D1 (de)	2003-09-25
CA2333629A1 (en)	1999-12-16
JP2003526601A (ja)	2003-09-09
CO5080802A1 (es)	2001-09-25
WO1999064423A1 (en)	1999-12-16
AU753897B2 (en)	2002-10-31
AU4277699A (en)	1999-12-30
PE20000734A1 (es)	2000-08-18
DE69910568T2 (de)	2004-06-17
ES2204171T3 (es)	2004-04-16
TW555759B (en)	2003-10-01
EP1086106A1 (de)	2001-03-28
EP1086106B1 (de)	2003-08-20
US6169090B1 (en)	2001-01-02

Publication	Publication Date	Title
AP1902A (en)	2008-10-15	N-aryl-2-oxazolidinone-5-carboxamides and their derivatives and their use as antibacterials
MA18694A1 (fr)	1980-10-01	Nouveaux derives de piperidinyl alkyl-quinazoline
DE69918422D1 (de)	2004-08-05	Phthalazinone pde iii/iv hemmer
BR0213140A (pt)	2004-10-19	Fungicidas de pirazol-pirimidina
TR200402157T2 (tr)	2005-02-21	Heteroaril süksinamidler ve metalloproteinaz inhibitörü olarak kullanımları
DE60226875D1 (de)	2008-07-10	Orthosubstituierte arylamide zur bekämpfung von wirbellosen schädlingen
NO953305D0 (no)	1995-08-23	Antranilsyrederivat
TW359670B (en)	1999-06-01	Process for producing quinazolin-4-one derivatives
ATE292628T1 (de)	2005-04-15	Chinazolinderivate
PT1140916E (pt)	2003-03-31	Acetais heteroarilo ciclicos
ATE180778T1 (de)	1999-06-15	Aryl- und heteroaryl- pyrimidine als herbizide
DE69910568D1 (de)	2003-09-25	Furopyridinderivate und ihre therapeutische verwendung
DE69821530D1 (de)	2004-03-11	Dihydrobenzifurane
MY100115A (en)	1989-12-18	Nitrogen containing heterocyclic compounds, and their production and use.
ATE102626T1 (de)	1994-03-15	Heterocyclische verbindungen, ihre darstellung und verwendung.
MX9706014A (es)	1998-02-28	Derivados de xanteno y acridina y su empleo.
AR027035A1 (es)	2003-03-12	Pirroles sustituidos
PT782574E (pt)	2002-08-30	Carboxamidas biciclicas como antagonistas 5-ht1a
TR199901474T2 (xx)	1999-09-21	�misazol t�revleri i�in proses.
TH48783A3 (th)	2001-12-25	สารประกอบเฮตเตอโรไซคลิค และการใช้ในการรักษา
ECSP992991A (es)	1999-10-06	Nuevos conceptos heterociclicos, su formulacion y uso como productos farmaceuticos
ATE17490T1 (de)	1986-02-15	Dithiino (1,4) (2,3-c) pyrrolderivate, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
MX9303555A (es)	1994-06-30	Derivados de quinoxalina, su preparacion y uso en medicamentos.

Legal Events

Date	Code	Title	Description
2004-02-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties